A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors
Novartis
Novartis
Prelude Therapeutics
Shanghai Junshi Bioscience Co., Ltd.
Incyte Corporation
Novartis
Novartis
Molecular Templates, Inc.
Eisai Inc.
Atreca, Inc.
Case Comprehensive Cancer Center